https://economictimes.indiatimes.com/markets/stocks/earnings/biocon-q1-results-profit-drops-30-yoy-to-rs-101-crore-revenue-jumps-59/articleshow/102618823.cms
0
0
46 words
0
Comments
The company attributed the drop in net profit to depreciation, amortisation and interest increase of Rs 353 crore over last year primarily related to the biosimilar business acquisition cost.
You are the first to view
Create an account or login to join the discussion